Tuesday, November 17, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Fiinews
No Result
View All Result
Home Markets

Markets: Intas collaborates with Nasdaq-linked Comera to innovate medicines

Fiinews by Fiinews
April 20, 2022
in Markets
Reading Time: 2 mins read
A A
0
Intas Pharmaceuticals
0
SHARES
10
VIEWS
LinkedinShare on Twitter

Chudgar to work with Comera to enhance therapeutic options and access for patients

Intas Pharmaceuticals Ltd of Ahmedabad has announced a research collaboration with Nasdaq-linked Comera Life Sciences to develop a new generation of bio-innovative biologic medicines to improve patient access, safety and convenience.

Under the terms of the partnership agreement, Comera will develop a differentiated formulation of an Intas product using Comera’s innovative proprietary SQore™ formulation platform.

Intas will initially provide research funding with the option to acquire global rights to the formulation through an exclusive license with responsibility for subsequent development and commercialization.

“We are excited to work with Comera to enhance therapeutic options and access for patients,” said Binish Chudgar, Vice Chairman and Managing Director of Intas Pharmaceuticals.

“This collaboration will accelerate our quest to develop innovative, value-added medicines that can make a difference in patients’ lives globally,” he added on 19 April 2022.

“This collaboration is the latest step in our long-term partnership strategy to leverage our SQore platform and transition from preclinical, early-stage assets to late-stage, marketed products,” said Jeff Hackman, President, Chief Executive Officer and Chairman of Comera which had combined its business earlier this year with OTR Acquisition Corp (Nasdaq: OTRA), a publicly traded special purpose acquisition company (SPAC).

“We look forward to working with Intas and developing a differentiated formulation that will make it easier for patients to use and increase healthcare savings.”

Intas Pharmaceuticals is a leading vertically integrated pharmaceutical company, having end-to-end capabilities of formulation development, manufacturing and marketing along with backward integration of APIs.

The organisation has more than 18,000 employees and 14 manufacturing sites worldwide and sells products in more than 85 countries. The Intas Group’s revenue amounted to USD 2.2 bn in FY 2020-21 and the compounded annual growth rate of revenue has been 19% in the past 5 years.

Leading a compassionate new era in medicine, Comera Life Sciences is applying a deep knowledge of formulation science and technology to transform essential biologic medicines.

The goal of this approach is to provide patients with the freedom of self-injectable care, reduce institutional dependency and to put patients at the center of their treatment regimen.

On 31 January 2022, Comera Life Sciences and OTR Acquisition Corp (Nasdaq: OTRA), a publicly traded special purpose acquisition company (SPAC), announced a proposed business combination. fiinews.com

Tags: Intas Pharmaceuticals Ltd
ShareTweetShare

Related Posts

Hanon Systems
Markets

Market: Hanon reinforced commitment to India

by Fiinews
November 16, 2026
0
10

Park will continue to develop thermal management solutions for Indian auto industry Hanon Systems, a leading global automotive thermal management...

DFI
Markets

Market: Drone industry set to grow to Rs.97,300cr

by Fiinews
November 16, 2026
0
20

200+ manufacturers making defence drones The Indian drone industry could grow from Rs.5,720 crore in 2025-26 to around Rs.97,300 crore...

ITPO

Market: Indians urged to do global business

November 16, 2026
20
Air India

Market: Air India seeks collaborations with airlines

November 14, 2026
22
Simplify Group

Market: Signify expands into water heaters in India

November 13, 2026
17
Beghou

Market: Beghou upgrades Pune to global centre

November 12, 2026
14
SBI YONO

Recent News

  • Export: India-Thailand traded $21.49bn in FY25-26
  • Export: India-Egypt set $12bn bilateral trade target
  • Manufacture: TN facility to produce from Dec 2026
  • Market: Hanon reinforced commitment to India
  • Project: PM dedicates Bengaluru terminal to nation

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY
  • About
  • Advertise
  • Careers
  • Contact us

© 2026 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEAN

© 2026 FIINEWS - Design and developed by 7clicksmedia.